HCPCS G8883: Biopsy Results Review, Communication, and Tracking

HCPCS Level II code G8883 denotes the clinical and administrative service of reviewing biopsy or pathology results, communicating findings to patients and ordering clinicians, tracking necessary follow-up, and documenting those actions. This code captures a non-procedural yet clinically important step in the diagnostic workflow that supports patient safety, continuity of care, and timely management decisions. Nationally, explicit coding for results review and communication can affect quality measurement, care coordination reporting, and administrative workflows across payers.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the kinds of services it represents. The publication also covers benchmarking considerations, common modifier usage (listed separately), and implications for documentation and billing workflows. Where specific payer policies differ or are not provided, the report notes that data are not available in the input. The content is intended to inform billing, compliance, and clinical documentation staff about the role and reporting of G8883 in outpatient biopsy result management.

Billing Code Overview

HCPCS Level II code G8883 represents biopsy results reviewed, communicated, tracked and documented. The service reflects activities associated with reviewing pathology or biopsy findings, communicating results to the patient and/or ordering clinician, tracking follow-up actions, and documenting those communications and care coordination steps in the medical record.

Service type: Results review and care coordination related to biopsy interpretation
Typical site of service: Ambulatory clinic, physician office, pathology or specialty practice, or other outpatient settings where biopsy care is managed

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical Context

A 58-year-old female undergoes an outpatient breast/core needle biopsy for a suspicious mammographic mass. The pathology laboratory generates a final pathology report confirming ductal carcinoma in situ. The ordering surgeon and primary care team review the biopsy results, communicate findings to the patient by telephone and secure patient portal message, document the communication in the medical record, track required follow-up (surgical consult, cancer center referral, genetic counseling as indicated), and ensure pathology specimens and reports are filed in the chart. Typical workflow: specimen is obtained in radiology or clinic, sent to pathology, pathologist issues a report, the ordering clinician reviews and documents review, the clinician communicates results to the patient, and follow-up appointments and referrals are scheduled and tracked until completed.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional work or complexity is documented for biopsy result review/coordination beyond typical effort.
`23`	Unusual anesthesia	Use when the service occurs with unusual anesthesia related to the biopsy procedure component.

Taxonomy Code	Specialty	Notes
207Q00000X	General Surgery	Surgeons who perform biopsies and review pathology results.
207K00000X	Surgical Oncology	Specialty managing cancer diagnoses from biopsy results and coordinating care.
207L00000X	Radiology	Interventional radiologists perform image-guided core needle biopsies and review reports.
207RC0000X	Pathology	Pathologists generate and finalize biopsy pathology reports.
261QR0400X	Medical Oncology	Medical oncologists involved in interpretation and planning after malignant biopsy results.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C50.912`	Malignant neoplasm of unspecified site of right female breast	Breast malignancy commonly identified on core needle biopsy requiring result review and treatment planning.
`D05.90`	Unspecified carcinoma in situ of breast	In situ breast lesions often diagnosed by biopsy and requiring documented communication and tracking.
`N63`	Unspecified lump in breast	Common indication for biopsy; pathology results determine diagnosis and next steps.
`R92.8`	Other abnormal and inconclusive findings on diagnostic imaging of breast	Imaging findings prompting biopsy and subsequent result communication.
`Z85.3`	Personal history of malignant neoplasm of breast	Relevant to follow-up and tracking of biopsy results in patients with prior breast cancer history.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`10021`	Fine needle aspiration without imaging guidance	Performed when cytologic sampling is used instead of core biopsy; precedes pathology reporting and review.
`11102`	Tangential biopsy of skin, single lesion, with closure	Skin biopsy technique that produces specimens requiring pathology review and documented communication.
`19083`	Biopsy of breast with placement of localization device, percutaneous, using imaging guidance	Image-guided breast biopsy example that results in pathology reports needing review, communication, and tracking.
`88305`	Level IV surgical pathology, gross and microscopic examination	Common pathology code for processing and reporting biopsy specimens; generates results that clinicians review and communicate.
`99499`	Unlisted evaluation and management service	Rarely used for complex coordination/documentation of biopsy results not described by other CPT codes.

OpenPayer

Summary & Overview